Venous Thromboembolism and Pregnancy

Overview

Journal J Blood Med

Publisher Dove Medical Press

Specialty Hematology

Date 2012 Jan 28

PMID 22282678

Citations 1

Authors

Maristella DUva

Pierpaolo Di Micco

Ida Strina

Giuseppe De Placido

Affiliations

Soon will be listed here.

Abstract

In recent decades, the association between a hypercoagulable state and its causes and adverse pregnancy outcome, in particular recurrent pregnancy loss (RPL) has been studied extensively. Although the first studies were focused only on the association between thrombophilia and RPL, subsequent studies underlined also a potential role of antithrombotic treatment to prevent vascular complication such as venous thromboembolism (VTE) during pregnancy. Thromboprophylaxis should be considered also for pregnant subjects carriers of molecular thrombophilia or that previously experienced VTE, in order to prevent VTE during pregnancy, while antithrombotic treatment for VTE should be performed during all pregnant periods.

Citing Articles

Cesarean section and osteosynthesis of lower limb fractures in the same surgical procedure.

Wajnsztejn A, Ejnisman L, Zlotnik E, Zitron L, Ejnisman B, Cohen M Int J Surg Case Rep. 2014; 5(2):111-3.

PMID: 24469261 PMC: 3921648. DOI: 10.1016/j.ijscr.2013.11.013.

References

Brancazio L, Roperti K, Stierer R, Laifer S . Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol. 1995; 173(4):1240-5. DOI: 10.1016/0002-9378(95)91362-9. View

Prandoni P, Tormene D, Simioni P, Girolami A . Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia. Clin Lab. 2001; 47(3-4):155-9. View

Sarig G, Younis J, Hoffman R, Lanir N, Blumenfeld Z, Brenner B . Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002; 77(2):342-7. DOI: 10.1016/s0015-0282(01)02971-5. View

Martinelli I . Risk factors in venous thromboembolism. Thromb Haemost. 2001; 86(1):395-403. View

Di Micco P, DUva M . The role of low molecular weight heparin to prevent miscarriage in thrombophilic women. Thromb Haemost. 2005; 94(5):897-8. DOI: 10.1160/TH05-10-0652. View

de Boer K, Ten Cate J, Sturk A, Borm J, Treffers P . Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989; 160(1):95-100. DOI: 10.1016/0002-9378(89)90096-3. View

Blanco-Molina A, Rota L, Di Micco P, Brenner B, Trujillo-Santos J, Ruiz-Gamietea A . Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb Haemost. 2010; 103(2):306-11. DOI: 10.1160/TH09-08-0559. View

Colman-Brochu S . Deep vein thrombosis in pregnancy. MCN Am J Matern Child Nurs. 2004; 29(3):186-92. DOI: 10.1097/00005721-200405000-00010. View

Greer I . Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol. 1998; 11(3):403-30. DOI: 10.1016/s0950-3552(97)80019-3. View

10.

Di Micco P, DUva M, Strina I, De Placido G, Di Fiore R, Quaranta S . Recurrent pregnancy loss and thrombophilia. Clin Lab. 2007; 53(5-6):309-14. View

11.

Brill-Edwards P, Ginsberg J, Gent M, Hirsh J, Burrows R, Kearon C . Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000; 343(20):1439-44. DOI: 10.1056/NEJM200011163432002. View

12.

Di Micco P, Amitrano M, Niglio A, Fontanella A . Molecular and clinical conditions associated with venous thromboembolism in oncological patients. Exp Oncol. 2006; 28(3):194-7. View

13.

Ginsberg J, Hirsh J . Use of antithrombotic agents during pregnancy. Chest. 1998; 114(5 Suppl):524S-530S. DOI: 10.1378/chest.114.5_supplement.524s. View

14.

Bates S . Treatment and prophylaxis of venous thromboembolism during pregnancy. Thromb Res. 2003; 108(2-3):97-106. DOI: 10.1016/s0049-3848(02)00399-7. View

15.

Blanco-Molina A, Trujillo-Santos J, Criado J, Lopez L, Lecumberri R, Gutierrez R . Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost. 2007; 97(2):186-90. View

16.

Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A . Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002; 17(6):1633-7. DOI: 10.1093/humrep/17.6.1633. View

17.

Phillips O . Venous thromboembolism in the pregnant woman. J Reprod Med. 2003; 48(11 Suppl):921-9. View

18.

Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe G . Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006; 132(2):171-96. DOI: 10.1111/j.1365-2141.2005.05847.x. View

19.

Eldor A . Thrombophilia, thrombosis and pregnancy. Thromb Haemost. 2001; 86(1):104-11. View